Specify a stock or a cryptocurrency in the search bar to get a summary
InspireMD Inc
NSPRInspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Address: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832
Analytics
WallStreet Target Price
4.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NSPR
Dividend Analytics NSPR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NSPR
Stock Valuation NSPR
Financials NSPR
Results | 2019 | Dynamics |